Escape from cardiomyocyte apoptosis by enterovirus persistence due to elevated soluble Fas-receptors

Zeitschrift fur Kardiologie

Volumn 93, Issue 7, 2004, Pages 524-532

  Alter, P ^a   Maisch, B ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Apoptosis; Cytokines; Enterovirus; Fas; Inflammatory heart disease; Myocarditis

Indexed keywords

FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADENOVIRUS; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENTEROVIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; MYOCARDITIS; NICK END LABELING; PERSISTENT VIRUS INFECTION; PROTEIN BLOOD LEVEL; VIRUS GENOME;

EID: 3242879792     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00392-004-0092-2     Document Type: Article

References (67)

1. Narula J, Pandey P, Arbustini E, Haider N, Narula N, Kolodgie FD, Dal Bello B, Semigran MJ, Bielsa-Masdeu A, Dec GW, Israels S, Ballester M, Virmani R, Saxena S, Kharbanda S (1999) Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci USA 96:8144-8149
2. MacLellan WR, Schneider MD (1997) Death by design. Programmed cell death in cardiovascular biology and disease. Circ Res 81:137-144
3. Schaper J, Elsasser A, Kostin S (1999) The role of cell death in heart failure. Circ Res 85:867-869
4. Anversa P, Kajstura J (1998) Myocyte cell death in the diseased heart. Circ Res 82:1231-1233
5. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw BA (1996) Apoptosis in myocytes in end-stage heart failure. N Engl J Med 335:1182-1189
6. Anversa P, Kajstura J, Olivetti G (1996) Myocyte death in heart failure. Curr Opin Cardiol 11:245-251
7. Colucci WS (1996) Apoptosis in the heart. N Engl J Med 335:1224-1226
8. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P (1997) Apoptosis in the failing human heart. N Engl J Med 336:1131-1141
9. Saraste A, Voipio-Pulkki LM, Parvinen M, Pulkki K (1997) Apoptosis in the heart. N Engl J Med 336:1025-1026
10. Yeh ET (1997) Life and death in the cardiovascular system. Circulation 95: 782-786
11. Seki Y, Kai H, Kai M, Muraishi A, Adachi K, Imaizumi T (1998) Myocardial DNA strand breaks are detected in biopsy tissues from patients with dilated cardiomyopathy. Clin Cardiol 21:591-596
12. Okuyama M, Yamaguchi S, Nozaki N, Yamaoka M, Shirakabe M, Tomoike H (1997) Serum levels of soluble form of Fas molecule in patients with congestive heart failure. Am J Cardiol 79:1698-1701
13. Yamaguchi S, Yamaoka M, Okuyama M, Nitoube J, Fukui A, Shirakabe M, Shirakawa K, Nakamura N, Tomoike H (1999) Elevated circulating levels and cardiac secretion of soluble Fas ligand in patients with congestive heart failure. Am J Cardiol 83:1500-1503, A8
14. Yamaoka M, Yamaguchi S, Suzuki T, Okuyama M, Nitobe J, Nakamura N, Mitsui Y, Tomoike H (2000) Apoptosis in rat cardiac myocytes induced by Fas ligand: priming for Fas-mediated apoptosis with doxorubicin. J Mol Cell Cardiol 32:881-889
15. Nishigaki K, Minatoguchi S, Seishima M, Asano K, Noda T, Yasuda N, Sano H, Kumada H, Takemura M, Noma A, Tanaka T, Watanabe S, Fujiwara H (1997) Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure. J Am Coll Cardiol 29:1214-1220
16. Toyozaki T, Hiroe M, Tanaka M, Nagata S, Ohwada H, Marumo F (1998) Levels of soluble Fas ligand in myocarditis. Am J Cardiol 82:246-248
17. Toyozaki T, Hiroe M, Saito T, Iijima Y, Takano H, Hiroshima K, Kohno H, Ishiyama S, Marumo F, Masuda Y, Ohwada H (1998) Levels of soluble Fas in patients with myocarditis, heart failure of unknown origin, and in healthy volunteers. Am J Cardiol 81:798-800
18. Pulkki KJ (1997) Cytokines and cardiomyocyte death. Ann Med 29:339-343
19. Alter P, Grimm W, Maisch B (2001) Varicella myocarditis in an adult. Heart 85:E2
20. Maisch B, Bauer E, Hufnagel G, Pfeifer U, Rohkamm R (1988) The use of endomyocardial biopsy in heart failure. Eur Heart J 9(Suppl H):59-71
21. Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ Jr, Olsen EG, Schoen FJ (1987) Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1:3-14
22. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93:841-842
23. Pankuweit S, Portig I, Eckhardt H, Crombach M, Hufnagel G, Maisch B (2000) Prevalence of viral genome in endomyocardial biopsies from patients with inflammatory heart muscle disease. Herz 25:221-226
24. Pulkki AS, Voipio-Pulkki LM (2000) Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy. Circulation 101:E239
25. Condorelli G, Morisco C, Stassi G, Notte A, Farina F, Sgaramella G, de Rienzo A, Roncarati R, Trimarco B, Lembo G (1999) Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptations to chronic pressure overload in the rat. Circulation 99:3071-3078
26. Zar JH (1984) Biostatistical Analysis. Englewood-Cliffs, NJ: Prentice-Hall
27. McCarthy RE III, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, Baughman KL (2000) Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 342:690-695
28. Weinstein C, Fenoglio JJ (1987) Myocarditis. Hum Pathol 18:613-618
29. Peters NS, Poole-Wilson PA (1991) Myocarditis-continuing clinical and pathologic confusion. Am Heart J 121:942-947
30. Marboe CC, Fenoglio JJ Jr (1988) Pathology and natural history of human myocarditis. Pathol Immunopathol Res 7:226-239
31. Pankuweit S, Hufnagel G, Eckhardt H, Herrmann H, Uttecht S, Maisch B (1998) Cardiotropic DNA viruses and bacteria in the pathogenesis of dilated cardiomyopathy with or without inflammation. Med Klin 93:223-228
32. Caforio AL, Bonifacio E, Keeling PJ, Grazzini M, Schiaffino S, Bottazzo GF, McKenna WJ (1992) Idiopathic dilated cardiomyopathy: a persistent viral infection or an organ-specific autoimmune disease? The trial of 2 major pathogenetic hypotheses. G Ital Cardiol 22:63-72
33. Maisch B, Herzum M, Hufnagel G, Bethge C, Schonian U (1995) Immunosuppressive treatment for myocarditis and dilated cardiomyopathy. Eur Heart J 16(Suppl O):153-161
34. Daly K, Richardson PJ, Olsen EG, Morgan-Capner P, McSorley C, Jackson G, Jewitt DE (1984) Acute myocarditis. Role of histological and virological examination in the diagnosis and assessment of immunosuppressive treatment. Br Heart J 51:30-35
35. Sabbah HN, Sharov VG (1998) Apoptosis in heart failure. Prog Cardiovasc Dis 40:549-562
36. Sabbah HN (2000) Apoptotic cell death in heart failure. Cardiovasc Res 45:704-712
37. Maisch B (1999) How cardiac cells die-necrosis, oncosis and apoptosis. Herz 24:181-188
38. Alter P, Jobmann M, Meyer E, Pankuweit S, Maisch B (2001) Apoptosis in myocarditis and dilated cardiomyopathy: Does enterovirus genome persistence protect from apoptosis? - An endomyocardial biopsy study. Cardiovasc Pathol 10:229-234
39. Colucci WS (1997) Molecular and cellular mechanisms of myocardial failure. Am J Cardiol 80:15L-25L
40. Cohen JJ (1993) Apoptosis, Immunol. Today 14:126-130
41. Squier MK, Cohen JJ (2000) Assays of apoptosis. Methods Mol Biol 144: 327-337
42. Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, Mattmann C, Burns K, Bodmer JL, Schroter M, Scaffidi C, Krammer PH, Peter ME, Tschopp J (1997) Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386:517-521
43. Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinen M, Voipio-Pulkki LM (1997) Apoptosis in human acute myocardial infarction. Circulation 95:320-323
44. Saraste A, Pulkki K (2000) Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res 45:528-537
45. Bellows DS, Chau BN, Lee P, Lazebnik Y, Burns WH, Hardwick JM (2000) Antiapoptotic herpesvirus Bcl-2 homologs escape caspase-mediated conversion to proapoptotic proteins. J Virol 74:5024-5031
46. Fuse K, Kodama M, Okura Y, Ito M, Hirono S, Kato K, Hanawa H, Aizawa Y (2000) Predictors of disease course in patients with acute myocarditis. Circulation 102:2829-2835
47. Nelson DP, Setser E, Hall DG, Schwartz SM, Hewitt T, Klevitsky R, Osinska H, Bellgrau D, Duke RC, Robbins J (2000) Proinflammatory consequences of transgenic fas ligand expression in the heart. J Clin Invest 105:1199-1208
48. Glykofrydes D, Niphuis H, Kuhn EM, Rosenwirth B, Heeney JL, Bruder J, Niedobitek G, Muller-Fleckenstein I, Fleckenstein B, Ensser A (2000) Herpesvirus saimiri vFLIP provides an antiapoptotic function but is not essential for viral replication, transformation, or pathogenicity. J Virol 74: 11919-11927
49. Kirshenbaum LA, de Moissac D (1997) The bcl-2 gene product prevents programmed cell death of ventricular myocytes. Circulation 96: 1580-1585
50. Cheng EH, Nicholas J, Bellows DS, Hayward GS, Guo HG, Reitz MS, Hardwick JM (1997) A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc Natl Acad Sci USA 94:690-694
51. Nambu Y, Hughes SJ, Rehemtulla A, Hamstra D, Orringer MB, Beer DG (1998) Lack of cell surface Fas/APO-1 expression in pulmonary adenocarcinomas. J Clin Invest 101:1102-1110
52. Trauth BC, Klas C, Peters AM, Matzku S, Moller P, Falk W, Debatin KM, Krammer PH (1989) Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301-305
53. Yonehara S, Ishii A, Yonehara M (1989) A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169:1747-1756
54. Knipping E, Debatin KM, Stricker K, Heilig B, Eder A, Krammer PH (1995) Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias. Blood 85:1562-1569
55. Seko Y, Kayagaki N, Seino K, Yagita H, Okumura K, Nagai R (2002) Role of Fas/FasL pathway in the activation of infiltrating cells in murine acute myocarditis caused by Coxsackievirus B3. J Am Coll Cardiol 39:1399-1403
56. Tanaka M, Suda T, Takahashi T, Nagata S (1995) Expression of the functional soluble form of human fas ligand in activated lymphocytes. EMBO J 14:1129-1135
57. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, Nagata S (1993) Lethal effect of the anti-Fas antibody in mice. Nature 364:806-809
58. Eberstadt M, Huang B, Chen Z, Meadows RP, Ng SC, Zheng L, Lenardo MJ, Fesik SW (1998) NMR structure and mutagenesis of the FADD (Mort1) death-effector domain. Nature 392:941-945
59. Yasuda N, Gotoh K, Minatoguchi S, Asano K, Nishigaki K, Nomura M, Ohno A, Watanabe M, Sano H, Kumada H, Sawa T, Fujiwara H (1998) An increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPD. Respir Med 92: 993-999
60. Ishiyama S, Hiroe M, Nishikawa T, Shimojo T, Abe S, Fujisaki H, Ito H, Yamakawa K, Kobayashi N, Kasajima T, Marumo F (1998) The Fas/Fas ligand system is involved in the pathogenesis of autoimmune myocarditis in rats. J Immunol 161:4695-4701
61. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85:817-827
62. Latif N, Khan MA, Birks E, O'Farrell A, Westbrook J, Dunn MJ, Yacoub MH (2000) Upregulation of the Bcl-2 family of proteins in end stage heart failure. J Am Coll Cardiol 35:1769-1777
63. Cook SA, Sugden PH, Clerk A (1999) Regulation of bcl-2 family proteins during development and in response to oxidative stress in cardiac myocytes: association with changes in mitochondrial membrane potential. Circ Res 85:940-949
64. Algeciras-Schimnich A, Griffith TS, Lynch DH, Paya CV (1999) Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis. J Immunol 162:5205-5211
65. Imanishi T, Murry CE, Reinecke H, Hano T, Nishio I, Liles WC, Hofsta L, Kim K, O'Brien KD, Schwartz SM, Han DK (2000) Cellular FLIP is expressed in cardiomyocytes and down-regulated in TUNEL-positive grafted cardiac tissues. Cardiovasc Res 48:101-110
66. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J (1997) Inhibition of death receptor signals by cellular FLIP. Nature 388:190-195
67. Willems F, Amraoui Z, Vanderheyde N, Verhasselt V, Aksoy E, Scaffidi C, Peter ME, Krammer PH, Goldman M (2000) Expression of c-FLIP(L) and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: inhibition by bisindolylmaleimide. Blood 95:3478-3482